At Spark® Therapeutics, we believe in a world where no life is limited by disease. We were born of innovation, springing from the curiosity, imagination and dedication of remarkable scientists and healthcare visionaries. Our mission is to unlock the power of gene therapy to accelerate healthcare transformation. Since our founding, we have been committed to bringing a wide range of expertise to build a fully integrated gene therapy company focused on inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver, such as hemophilia. We are seeking talented individuals with diverse experiences, abilities and interests who have the curiosity, courage and drive to reimagine a new health care paradigm. Join us on a journey through uncharted territory – seeking to bring gene therapy to people worldwide. The resilience of the people we serve is our inspiration to break barriers, as we strive to turn genes into medicine. Spark is a member of the Roche Group. Know that working at Spark® Therapeutics is not just another job; it is a once-in-a-lifetime opportunity. We embrace the challenges before us and the uncertainty inherent in them. Ultimately, we are working to create a world where no life is limited by disease. To learn more about Spark and our open positions, visit www.sparktx.com. You can also find us on Twitter at @Spark_tx. Spark’s social media sites are monitored from Monday to Friday during normal business hours. Questions or concerns should be directed here: https://sparktx.com/contact-us/.
View Top Employees from Spark Therapeutics, Inc.Website | http://www.sparktx.com |
Ticker | ONCE |
Revenue | $236.3 million |
Funding | $1 billion |
Employees | 1,031 (1,031 on RocketReach) |
Founded | 2013 |
Address | 3737 Market Street Suite 1300, Philadelphia, Pennsylvania 19104, US |
Phone | (215) 220-9300 |
Technologies |
JavaScript,
HTML,
PHP
+76 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Healthcare, Science and Engineering, Gene therapy, Genetics, Health Care, Medical, Therapeutics |
Web Rank | 1 Million |
Keywords | Gene Editing, Neurodegenerative Diseases, Genetic Testing, Rare Disease, Molecular Medicine, Biotechnology |
Competitors | Asklepios BioPharmaceutical, Inc. (AskBio), Freeline, MeiraGTx, REGENXBIO Inc., Voyager Therapeutics, Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325414 Companies |
Looking for a particular Spark Therapeutics, Inc. employee's phone or email?
The Spark Therapeutics, Inc. annual revenue was $236.3 million in 2024.
Ron Philip is the CEO of Spark Therapeutics, Inc..
1,031 people are employed at Spark Therapeutics, Inc..
Spark Therapeutics, Inc. is based in Philadelphia, Pennsylvania.
The NAICS codes for Spark Therapeutics, Inc. are [325, 32, 3254, 32541, 325414].
The SIC codes for Spark Therapeutics, Inc. are [283, 28].